Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).
NCT: NCT07705100 · NOT_YET_RECRUITING
Brief Summary
The investigators are doing this study to find out if a new kind of breast imaging (called upright dedicated breast CT or UBCT) can help doctors to see the small structures in breast tissue more clearly in 3-D and without overlap. The breast imaging device that will be used in this study (UBCT) is not FDA-approved, so this is a research study. The machine has been designed to remove mammography-like breast compression and use radiation dose comparable to mammography. The breast CT device will take multiple x-ray pictures of the subjects breast in approximately 20 seconds and create a 3-D image of the breast. It does not compress or squish the breast like a mammogram.
Frequently Asked Questions
What is Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).?
Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT). is a clinical trial registered under NCT07705100. Current status: NOT_YET_RECRUITING.
What is the status of NCT07705100?
The current status of NCT07705100 (Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).) is: NOT_YET_RECRUITING.
When did Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT). start?
Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT). started on 2026-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.